Black cohosh: Considerations of safety and benefit

Nutrition Today

Volumn 44, Issue 4, 2009, Pages 155-162

  Betz, Joseph M ^a   Anderson, Linda ^b   Avigan, Mark I ^c   Barnes, Joanne ^d   Farnsworth, Norman R ^e   Gerdén, Barbro ^f   Henderson, Leigh ^b   Kennelly, Edward J ^g   Koetter, Uwe ^h   Lessard, Stephanie ⁱ   Dog, Tieraona Low ^j   McLaughlin, Michelle ^k   Naser, Belal ^l   Osmers, Ruediger G W ^m   Pellicore, Linda S ^c   Senior, John R ^c   Van Breemen, Richard B ^e   Wuttke, Wolfgang ⁿ   Cardellina, John H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f MEDICAL PRODUCTS AGENCY   (Sweden)

^g CITY UNIVERSITY OF NEW YORK   (United States)

^h Max Zeller Söhne AG   (Switzerland)

ⁱ Bureau of Clinical Trials and Health Sciences   (Canada)

^j UNIVERSITY OF ARIZONA   (United States)

^k THERAPEUTIC GOODS ADMINISTRATION   (Australia)

^l Schaper & Brummer GmbH & Co KG   (Germany)

^m Department of Obstetrics and Gynecology   (Germany)

ⁿ UNIVERSITY OF GÖTTINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69649105034     PISSN: 0029666X     EISSN: 15389839     Source Type: Journal    
DOI: 10.1097/NT.0b013e3181af63f9     Document Type: Article

References (51)

1. Compton JA, Culham A, Gibbings JG, Jury SL. Phylogeny of Actaea including Cimicifuga (Ranunculaceae) inferred from nrDNA ITS sequence variation. Biochem Syst Ecol. 1998;26:185Y197.
2. Compton JA, Culham AC, Jury SL. Reclassification of Actaea to include Cimicifuga and Souliea (Ranunculaceae): phylogeny inferred from morphology, nrDNA ITS, and cpDNA trrD-F sequence variation. Taxon. 1998;47:593Y634.
3. Moerman DE. North American Ethnobotany. Portland, OR: Timber Press Inc; 1998.
4. Workshop on the safety of black cohosh in clinical studies. NCCAM Web site. http://nccam.nih.gov/news/ pastmeetings/blackcohosh-mtngsumm.pdf#intro. Accessed September 22, 2008.
5. Davis VL, Jayo MJ, Hardy ML, et al. Effects of black cohosh on mammary tumor development and progression in MMTV-neu transgenic mice. Presented at the 94th Annual Meeting of the American Association for Cancer Research. Proc AACR. April 2003. Abstract no. 910.
6. Fabricant DS, Nikolic D, Lankin DC, et al. Cimipronidine, a cyclic guanidine alkaloid from Cimicifuga racemosa. J Nat Prod. 2005;68:1266Y1270.
7. European Directorate for the Quality of Medicines. Herbal drug preparations (1434). In: European Pharmacopoeia. 4th ed. Strasbourg: European Directorate for the Quality of Medicines; 2003:510.
8. Nuntanakorn P, Jiang B, Yang H, Cervantes-Cervantes M, Kronenberg F, Kennelly EJ. Analysis of polyphenolic compounds and radical scavenging activity of four American Actaea species. Phytochem Anal. 2007;18:219Y228.
9. Avula B, Ali Z, Khan IA. Chemical fingerprinting of Actaea racemosa (black cohosh) and its comparison study with closely related Actaea species (A. pachypoda, A. podocarpa, A. rubra) by HPLC. Chromatographia. 2007;66:757Y762.
10. He K, Pauli GF, Zheng B, et al. Cimicifuga species identification by high performance liquid chromatography-photodiode array/mass spectrometric/ evaporative light scattering detection for quality control of black cohosh products. J Chromatogr A. 2006;1112:241Y254.
11. Gafner S, Sudberg S, Sudberg EM, Villinski JR, Gauthier R, Bergeron C. Chromatographic fingerprinting as a means of quality control: distinction between Actaea racemosa and four different Actaea species. Acta Hort. 2006;720:83Y94.
12. Jiang B, Kronenberg F, Nuntanakorn P, Qiu M-H, Kennelly EJ. Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high performance liquid chromatography with selected ion monitoring liquid-chromatography mass spectrometry. J Agric Food Chem. 2006;54:3242Y3253.
13. Biologically active agents used in CAM and placebo materialsVpolicy and guidance. NCCAM Web site. http://nccam.nih.gov/research/policies/bioactive.htm. Accessed September 22, 2008.
14. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005;20:30Y35.
15. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105:1074Y1083.
16. Wuttke W, Rau K, Gorkow C. Efficacy and tolerability of the black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogensYcontrolled study. Maturitas. 2006;558:S83YS91.
17. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med. 2006;145:869Y879.
18. Bai W, Henneicke-von Zepelin HH, Wang S, et al. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas. 2007;58:31Y41.
19. Rhyu M-R, Lu J, Webster DE, Frabricant DS, Farnsworth NR, Wang ZJ. Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human 6 opiate receptor. J Agric Food Chem. 2006;54:9852Y9857.
20. Burdette JE, Liu J, Chen S-N, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51:5661Y5670.
21. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas. 2003;44 suppl 1:S31YS38.
22. Reame NK. The emerging science of hot flash relief: legitimizing the ''obecalp'' effect. Menopause. 2005;12:4Y7.
23. Reame NE, Lukacs JL, Padmanabhan V, Eyvazzadeh AD, Smith YR, Zubieta J-K. Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause. 2008;15:832Y840.
24. Liu ZP, Yu B, Huo JS, Lu CQ, Chen JS. Estrogenic effects of Cimicifuga racemosa (black cohosh) in mice and on estrogen receptors in MCF-7 cells. J Med Food. 2001;4:171Y178.
25. Rockwell S, Liu Y, Higgins SA. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat. 2005;90:233Y239.
26. Al-Akoum M, Dodin S, Akoum A. Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study. Can J Physiol Pharmacol. 2007;85:1153Y1159.
27. Bolle P, Mastrangelo S, Perrone F, Evandi MG. Estrogen-like effect of a Cimicifuga racemosa extract subfraction as assessed by in vivo, ex vivo and in vitro assays. J Steroid Biochem Mol Biol. 2007;107:262Y269.
28. Einbond LS, Su T, Wu H-a, et al. The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways. Int J Cancer. 2007;121:2073Y2083.
29. Einbond LS, Su T, Wu H-a, et al. Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. Anticancer Res. 2007;27:697Y712.
30. Einbond LS, Ye W-C, He K, et al. Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells. Phytomedicine. 2008;15:504Y511.
31. Gaube F, Wolfl S, Pusch L, Kroll TC, Hamburger M. Gene expression profiling reveals effects of Cimicifuga racemosa (L.) Nutt. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7. BMC Pharmacol. 2007;7:11.
32. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Inhibitory effect of an isopropanolic extract of black cohosh on the invasiveness of MDA-MB 231 human breast cancer cells. In Vivo. 2007;21:349Y356.
33. Rice S, Amon A, Whitehead SA. Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells. Maturitas. 2007;56:359Y367.
34. Seidlov"-Wuttke D, Wuttke W. Effects of various phytoestrogens and of Cimicifuga racemosa (CR) in the mammary gland of ovariectomized (ovx) rats. Z Phytother. 2008;29(suppl1):16.
35. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahifs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizome): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med. 2002;11:163Y174.
36. Ruhlen RL, Haubner J, Tracy JK, et al. Black cohosh does not exert an estrogenic effect on the breast. Nutr Cancer. 2007;59:269Y277.
37. Stute P, Nisslein T, GPtte M, Kamischke A, Kiesel L, Klockenbusch W. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro. Maturitas. 2007;57:382Y391.
38. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001;49:2472Y2479.
39. Kretzschmar G, Nisslein T, Zierau O, Vollmer G. No effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment. J Steroid Biochem Mol Biol. 2005;97:271Y277.
40. Rau K, Brucker C, Gorkow C, Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause. 2006;13:678Y691.
41. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause. 2008;15:51Y58.
42. Hirschberg AL, Edlund M, Svane G, Azavedo E, Skoog L, Von Schoultz B. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause. 2007;14:89Y96.
43. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2002;177:432Y435.
44. Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosa rhizome (black cohosh, root). European Medicines Agency Web site. http:// www.emea.europa.eu/pdfs/human/hmpc/26925806en.pdf. Accessed September 22, 2008.
45. Teschke R, Schwarzenboeck A. Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine. 2009;16:72Y84.
46. Levitsky J, Alli TA, Wisecarver J, Sorrel MF. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci. 2005;50:538Y539.
47. Levitsky J, Alli TA, Wisecarver J, Sorrel MF. Fulminant liver failure associated with the use of black cohosh [erratum]. Dig Dis Sci. 2008;53:869.
48. Marles RJ, Jordan S, Murty M, Perwaiz S, Bertrand R, Lacroix P. Herb misidentification in a black cohosh product adverse reaction case [abstract]. Presented at the 5th Annual Natural Health Products Research Conference; March 2008; Toronto, Ontario, Canada.
49. Walker AM, Cavanaugh RJ. The occurrence of new hepatic disorders in a defined population. Post Mark Surveill. 1992;6:107Y117.
50. Kelly WN, Arellano FM, Barnes J, et al. International Society of Pharmacoepidemiology; International Society for Pharmacovigilance. Guidelines for submitting adverse event reports for publication. Drug Saf. 2007;30:367Y373. (Pubitemid 46740334)
51. The NIH funds network to study drug-induced liver injury (DILIN). NIH News Web site. http://www.nih.gov/news/pr/ nov2004/niddk-19.htm. Accessed September 22, 2008.